TIL
Income statement / Annual
Last year (2025), Instil Bio Inc's total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2025, Instil Bio Inc's net income was -$71.37 M.
See Instil Bio Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$138.00 K |
$0.00 |
| Cost of Revenue |
$534.00 K
|
$0.00
|
$0.00
|
$5.99 M
|
$0.00
|
$0.00
|
$20.00 K
|
| Gross Profit |
-$534.00 K
|
$0.00
|
$0.00
|
-$5.99 M
|
$0.00
|
$138.00 K
|
-$20.00 K
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
| Research and Development Expenses |
$10.00 M
|
$11.84 M
|
$39.60 M
|
$141.06 M
|
$107.25 M
|
$19.40 M
|
$4.03 M
|
| General & Administrative Expenses |
$27.22 M
|
$44.21 M
|
$47.55 M
|
$62.24 M
|
$48.31 M
|
$14.38 M
|
$2.56 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$3.00 M
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$27.22 M
|
$44.21 M
|
$47.55 M
|
$62.24 M
|
$51.31 M
|
$14.38 M
|
$2.56 M
|
| Other Expenses |
$15.15 M
|
$17.49 M
|
$72.01 M
|
-$3.11 M
|
-$3.00 M
|
$0.00
|
$0.00
|
| Operating Expenses |
$52.37 M
|
$73.54 M
|
$159.17 M
|
$200.18 M
|
$155.56 M
|
$33.78 M
|
$6.59 M
|
| Cost And Expenses |
$52.91 M
|
$73.54 M
|
$159.17 M
|
$206.17 M
|
$155.56 M
|
$33.78 M
|
$6.59 M
|
| Interest Income |
$3.86 M
|
$6.99 M
|
$8.87 M
|
$3.66 M
|
$80.00 K
|
$70.00 K
|
$68.00 K
|
| Interest Expense |
$5.83 M
|
$8.99 M
|
$5.21 M
|
$1.88 M
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$534.00 K
|
$3.61 M
|
$4.76 M
|
$5.99 M
|
$2.75 M
|
$256.00 K
|
$20.00 K
|
| EBITDA |
-$52.37 M |
-$62.53 M |
-$147.12 M |
-$217.38 M |
-$152.51 M |
-$33.39 M |
-$6.50 M |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
-241.94
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
-243.8
|
0
|
| Total Other Income/Expenses Net |
-$18.47 M
|
-$594.00 K
|
$3.08 M
|
-$19.08 M
|
-$1.20 M
|
-$3.94 M
|
$63.00 K
|
| Income Before Tax |
-$71.37 M
|
-$74.14 M
|
-$156.09 M
|
-$225.25 M
|
-$156.76 M
|
-$37.59 M
|
-$6.52 M
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
-272.37
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
-$2.07 M
|
$39.00 K
|
$151.00 K
|
$0.00
|
| Net Income |
-$71.37 M
|
-$74.14 M
|
-$156.09 M
|
-$223.18 M
|
-$156.79 M
|
-$37.74 M
|
-$6.45 M
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
-273.46
|
0
|
| EPS |
-10.7 |
-11.39 |
-24 |
-34.46 |
-29.6 |
-5.89 |
-1.01 |
| EPS Diluted |
-10.7 |
-11.39 |
-24 |
-34.46 |
-29.6 |
-5.89 |
-1.01 |
| Weighted Average Shares Out |
$6.67 M
|
$6.51 M
|
$6.50 M
|
$6.48 M
|
$5.30 M
|
$6.41 M
|
$6.41 M
|
| Weighted Average Shares Out Diluted |
$6.67 M
|
$6.51 M
|
$6.50 M
|
$6.48 M
|
$5.30 M
|
$6.41 M
|
$6.41 M
|
| Link |
|
|
|
|
|
|
|
